Author:
Fu Dian,Cao Ruiyuan,Zhao Lei,Li Wei,Zhong Wu,Wen Jiqiu
Funder
National Science and Technology Major Project
National Key R&D program of China
Publisher
Springer Science and Business Media LLC
Subject
Critical Care and Intensive Care Medicine
Reference4 articles.
1. Johns Hopkins University and Medicine. COVID-19 map. Johns Hopkins Coronavirus Resource Centre. https://coronavirus.jhu.edu/map.html. Accessed 22 July 2020.
2. Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30(3):269–71.
3. Cai Q, Yang M, Liu D, Chen J, Shu D, Xia J, et al. Experimental treatment with favipiravir for COVID-19: an open-label control study. Eng (Beijing). 2020. https://doi.org/10.1016/j.eng.2020.03.007.
4. Wang X, Zhou Y, Jiang N, Zhou Q, Ma W. Persistence of intestinal SARS-CoV-2 infection in patients with COVID-19 leads to re-admission after pneumonia resolved. Int J Infect Dis. 2020;95:433–5. https://doi.org/10.1016/j.ijid.2020.04.063.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献